US Stock MarketDetailed Quotes

VCEL Vericel

Watchlist
  • 56.500
  • +1.550+2.82%
Close Dec 20 16:00 ET
  • 56.500
  • 0.0000.00%
Post 20:05 ET
2.79BMarket Cap706.25P/E (TTM)

Vericel Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
27.04%57.91M
14.68%52.66M
25.02%51.28M
20.17%197.52M
23.35%65M
18.24%45.58M
23.96%45.92M
13.70%41.02M
5.24%164.37M
10.72%52.69M
Operating revenue
27.04%57.91M
14.68%52.66M
25.02%51.28M
20.66%197.52M
23.35%65M
18.93%45.58M
24.70%45.92M
14.41%41.02M
6.94%163.7M
12.00%52.69M
Cost of revenue
8.54%16.25M
0.50%16.06M
9.86%15.93M
13.49%61.94M
14.15%16.49M
12.43%14.97M
12.61%15.98M
14.86%14.5M
8.81%54.58M
6.53%14.45M
Gross profit
36.09%41.65M
22.24%36.6M
33.31%35.35M
23.49%135.58M
26.82%48.51M
21.30%30.61M
31.01%29.94M
13.08%26.52M
3.55%109.79M
12.39%38.25M
Operating expense
23.70%44.12M
18.75%42.63M
17.64%40.82M
11.98%142.04M
11.23%35.78M
11.38%35.67M
12.42%35.9M
12.93%34.7M
11.39%126.85M
7.60%32.16M
Selling and administrative expenses
26.80%38.03M
15.07%35.27M
16.67%34.4M
13.18%121M
14.70%30.88M
11.17%29.99M
12.91%30.65M
14.00%29.49M
9.54%106.9M
3.67%26.92M
Research and development costs
7.35%6.09M
40.17%7.36M
23.14%6.42M
5.51%21.04M
-6.56%4.9M
12.49%5.68M
9.62%5.25M
7.24%5.21M
22.45%19.94M
33.66%5.25M
Operating profit
51.26%-2.47M
-1.17%-6.03M
33.18%-5.46M
62.11%-6.46M
109.22%12.73M
25.50%-5.06M
34.36%-5.96M
-12.43%-8.18M
-117.19%-17.06M
46.95%6.09M
Net non-operating interest income expense
28.06%1.42M
43.45%1.36M
131.84%1.61M
313.54%4.03M
137.04%1.28M
369.20%1.11M
639.06%946K
891.43%694K
343.18%975K
800.00%540K
Non-operating interest income
25.04%1.58M
37.90%1.51M
110.01%1.76M
245.41%4.63M
88.20%1.44M
269.01%1.26M
639.86%1.1M
853.41%839K
498.66%1.34M
1,150.82%763K
Non-operating interest expense
2.67%154K
2.68%153K
5.52%153K
63.93%600K
-30.04%156K
42.86%150K
645.00%149K
705.56%145K
9,050.00%366K
22,200.00%223K
Other net income (expense)
14,100.00%140K
-60.00%-8K
41.67%-7K
-32.63%64K
2,833.33%82K
80.00%-1K
44.44%-5K
-110.71%-12K
82.69%95K
-137.50%-3K
Other non- operating income (expenses)
14,100.00%140K
-60.00%-8K
41.67%-7K
-32.63%64K
2,833.33%82K
80.00%-1K
44.44%-5K
-110.71%-12K
82.69%95K
-137.50%-3K
Income before tax
77.17%-901K
6.73%-4.68M
48.47%-3.86M
85.19%-2.37M
112.82%14.09M
39.81%-3.95M
43.99%-5.02M
-5.70%-7.5M
-110.87%-15.99M
57.33%6.62M
Income tax
0
12.90%814K
57.14%1.1M
-1,461.90%-286K
749.55%721K
314.72%700K
Net income
75.38%-901K
6.73%-4.68M
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
Net income continuous Operations
75.38%-901K
6.73%-4.68M
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
Minority interest income
Net income attributable to the parent company
75.38%-901K
6.73%-4.68M
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
75.38%-901K
6.73%-4.68M
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
Basic earnings per share
75.00%-0.02
9.09%-0.1
50.00%-0.08
80.00%-0.07
107.69%0.27
42.86%-0.08
42.11%-0.11
-6.67%-0.16
-118.75%-0.35
30.00%0.13
Diluted earnings per share
75.00%-0.02
9.09%-0.1
50.00%-0.08
80.00%-0.07
125.00%0.27
42.86%-0.08
42.11%-0.11
-6.67%-0.16
-118.75%-0.35
33.33%0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 27.04%57.91M14.68%52.66M25.02%51.28M20.17%197.52M23.35%65M18.24%45.58M23.96%45.92M13.70%41.02M5.24%164.37M10.72%52.69M
Operating revenue 27.04%57.91M14.68%52.66M25.02%51.28M20.66%197.52M23.35%65M18.93%45.58M24.70%45.92M14.41%41.02M6.94%163.7M12.00%52.69M
Cost of revenue 8.54%16.25M0.50%16.06M9.86%15.93M13.49%61.94M14.15%16.49M12.43%14.97M12.61%15.98M14.86%14.5M8.81%54.58M6.53%14.45M
Gross profit 36.09%41.65M22.24%36.6M33.31%35.35M23.49%135.58M26.82%48.51M21.30%30.61M31.01%29.94M13.08%26.52M3.55%109.79M12.39%38.25M
Operating expense 23.70%44.12M18.75%42.63M17.64%40.82M11.98%142.04M11.23%35.78M11.38%35.67M12.42%35.9M12.93%34.7M11.39%126.85M7.60%32.16M
Selling and administrative expenses 26.80%38.03M15.07%35.27M16.67%34.4M13.18%121M14.70%30.88M11.17%29.99M12.91%30.65M14.00%29.49M9.54%106.9M3.67%26.92M
Research and development costs 7.35%6.09M40.17%7.36M23.14%6.42M5.51%21.04M-6.56%4.9M12.49%5.68M9.62%5.25M7.24%5.21M22.45%19.94M33.66%5.25M
Operating profit 51.26%-2.47M-1.17%-6.03M33.18%-5.46M62.11%-6.46M109.22%12.73M25.50%-5.06M34.36%-5.96M-12.43%-8.18M-117.19%-17.06M46.95%6.09M
Net non-operating interest income expense 28.06%1.42M43.45%1.36M131.84%1.61M313.54%4.03M137.04%1.28M369.20%1.11M639.06%946K891.43%694K343.18%975K800.00%540K
Non-operating interest income 25.04%1.58M37.90%1.51M110.01%1.76M245.41%4.63M88.20%1.44M269.01%1.26M639.86%1.1M853.41%839K498.66%1.34M1,150.82%763K
Non-operating interest expense 2.67%154K2.68%153K5.52%153K63.93%600K-30.04%156K42.86%150K645.00%149K705.56%145K9,050.00%366K22,200.00%223K
Other net income (expense) 14,100.00%140K-60.00%-8K41.67%-7K-32.63%64K2,833.33%82K80.00%-1K44.44%-5K-110.71%-12K82.69%95K-137.50%-3K
Other non- operating income (expenses) 14,100.00%140K-60.00%-8K41.67%-7K-32.63%64K2,833.33%82K80.00%-1K44.44%-5K-110.71%-12K82.69%95K-137.50%-3K
Income before tax 77.17%-901K6.73%-4.68M48.47%-3.86M85.19%-2.37M112.82%14.09M39.81%-3.95M43.99%-5.02M-5.70%-7.5M-110.87%-15.99M57.33%6.62M
Income tax 012.90%814K57.14%1.1M-1,461.90%-286K749.55%721K314.72%700K
Net income 75.38%-901K6.73%-4.68M48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M
Net income continuous Operations 75.38%-901K6.73%-4.68M48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M
Minority interest income
Net income attributable to the parent company 75.38%-901K6.73%-4.68M48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 75.38%-901K6.73%-4.68M48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M
Basic earnings per share 75.00%-0.029.09%-0.150.00%-0.0880.00%-0.07107.69%0.2742.86%-0.0842.11%-0.11-6.67%-0.16-118.75%-0.3530.00%0.13
Diluted earnings per share 75.00%-0.029.09%-0.150.00%-0.0880.00%-0.07125.00%0.2742.86%-0.0842.11%-0.11-6.67%-0.16-118.75%-0.3533.33%0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme CAR-T Therapy
CAR-T Therapy
Intraday+0.97%